Home » Stocks » Neogen Corporation

Neogen Corporation (NEOG)

Stock Price: $77.18 USD -0.28 (-0.36%)
Updated Aug 4, 2020 12:46 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 4.09B
Revenue (ttm) 418.17M
Net Income (ttm) 59.48M
Shares Out 52.91M
EPS (ttm) 1.13
PE Ratio 68.30
Forward PE 61.73
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 4, 2020
Last Price $77.18
Previous Close $77.46
Change ($) -0.28
Change (%) -0.36%
Day's Open 77.16
Day's Range 76.66 - 78.03
Day's Volume 37,808
52-Week Range 48.91 - 80.84

More Stats

Market Cap 4.09B
Enterprise Value 3.74B
Earnings Date (est) Sep 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 52.91M
Float 52.70M
EPS (basic) 1.13
EPS (diluted) 1.13
FCF / Share 1.18
Dividend n/a
Dividend Yield n/a
Earnings Yield 1.46%
FCF Yield 1.51%
Payout Ratio n/a
Shares Short 2.71M
Short Ratio 11.41
Short % of Float 7.71%
Beta 0.74
PE Ratio 68.30
Forward PE 61.73
P/FCF Ratio 66.10
PS Ratio 9.77
PB Ratio 5.50
Revenue 418.17M
Operating Income 67.52M
Net Income 59.48M
Free Cash Flow 61.83M
Net Cash 343.67M
Net Cash / Share 6.49
Gross Margin 46.94%
Operating Margin 16.15%
Profit Margin 14.20%
FCF Margin 14.78%
ROA 5.65%
ROE 8.73%
ROIC 15.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy 1
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$81.50*
(5.60% upside)
Low
75.0
Current: $77.18
High
88.0
Target: 81.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2020201920182017201620152014201320122011
Revenue418414398358321283247208184173
Revenue Growth0.96%4.09%11.07%11.52%13.5%14.42%19.22%12.76%6.58%-
Gross Profit19619218616915314012310992.4387.79
Operating Income67.5268.0970.1964.9556.3953.1243.3940.7133.7435.84
Net Income59.4860.1863.1543.7936.5633.5328.1627.1922.5122.84
Shares Outstanding52.5551.8951.3650.8350.0349.3948.8947.8447.1146.38
Earnings Per Share1.131.151.210.860.720.680.570.560.470.48
EPS Growth-1.74%-4.96%40.7%19.44%6.67%18.42%1.24%21.08%-3.12%-
Operating Cash Flow85.8863.8469.1360.2735.3343.7921.6726.5622.2828.84
Capital Expenditures-24.05-14.66-20.95-14.58-14.22-9.62-11.54-8.90-12.41-7.80
Free Cash Flow61.8349.1848.1945.7021.1134.1710.1317.669.8621.05
Cash & Equivalents34426821114410811476.5085.3768.6556.08
Net Cash / Debt34426821114410811476.5085.3768.6556.08
Assets797696618528450392345291252220
Liabilities72.0157.8457.8356.6545.7841.2239.0032.2732.5530.68
Book Value725638560472404351306258219189
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Neogen Corporation
Country United States
Employees 1,764
CEO John E. Adent

Stock Information

Ticker Symbol NEOG
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: NEOG
IPO Date August 23, 1989

Description

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and the Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.